Familial Mediterranean Fever
Last Posted: Apr 28, 2022
- Familial Mediterranean Fever: How to Interpret Genetic Results? How to Treat? A Quarter of a Century After the Association with the Mefv Gene.
Batu Ezgi Deniz et al. Current rheumatology reports 2022
- Real-Life Data From the Largest Pediatric Familial Mediterranean Fever Cohort.
Öztürk Kübra et al. Frontiers in pediatrics 2022 9805919
- Prediction of More Severe MEFV Gene Mutations in Childhood.
Günes-Yilmaz Seviye et al. Turkish archives of pediatrics 2022 56(6) 610-617
- Comparison of diagnostic criteria for children with familial Mediterranean fever.
Akyol Onder Esra Nagehan et al. European journal of pediatrics 2022
- Parental knowledge about familial Mediterranean fever: a cross-sectional study.
Yildirim Deniz Gezgin et al. The Turkish journal of pediatrics 2022 63(6) 1048-1055
- Efficacy and safety of canakinumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: A single-centre observational study.
Tomokawa Takuya et al. Modern rheumatology 2021
- The remarkable characteristics of the children with colchicine-resistant familial Mediterranean fever in Turkey.
Sahin Nihal et al. Modern rheumatology 2021
- Clinical course of COVID-19 infection in paediatric familial Mediterranean fever patients.
Kaya Akca Ummusen et al. Modern rheumatology 2021
- The Assessment of Selected miRNA Profile in Familial Mediterranean Fever.
Kahraman Cigdem Yuce et al. BioMed research international 2021 20216495700
- The analysis of genotype-phenotype correlation in familial Mediterranean fever.
Öztürk Kübra et al. Pediatrics international : official journal of the Japan Pediatric Society 2021
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Graves Disease
- Huntington Disease
- Myasthenia Gravis
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.